CRDF
Price
$1.12
Change
-$0.06 (-5.08%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
93.35M
27 days until earnings call
Intraday BUY SELL Signals
DBVT
Price
$10.55
Change
-$0.66 (-5.89%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
740.8M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRDF vs DBVT

CRDF vs DBVT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRDF vs. DBVT commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Hold and DBVT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CRDF vs DBVT: Fundamental Ratings
CRDF
DBVT
OUTLOOK RATING
1..100
9461
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5465
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DBVT's Valuation (44) in the Biotechnology industry is in the same range as CRDF (47) in the null industry. This means that DBVT’s stock grew similarly to CRDF’s over the last 12 months.

DBVT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRDF (100) in the null industry. This means that DBVT’s stock grew similarly to CRDF’s over the last 12 months.

CRDF's SMR Rating (98) in the null industry is in the same range as DBVT (99) in the Biotechnology industry. This means that CRDF’s stock grew similarly to DBVT’s over the last 12 months.

CRDF's Price Growth Rating (54) in the null industry is in the same range as DBVT (65) in the Biotechnology industry. This means that CRDF’s stock grew similarly to DBVT’s over the last 12 months.

CRDF's P/E Growth Rating (100) in the null industry is in the same range as DBVT (100) in the Biotechnology industry. This means that CRDF’s stock grew similarly to DBVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDFDBVT
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
84%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (CRDF: $1.18 vs. DBVT: $11.21)
Brand notoriety: CRDF and DBVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 33% vs. DBVT: 151%
Market capitalization -- CRDF: $93.35M vs. DBVT: $740.8M
CRDF [@Biotechnology] is valued at $93.35M. DBVT’s [@Biotechnology] market capitalization is $740.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green while DBVT’s FA Score has 0 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • DBVT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRDF and DBVT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 5 TA indicator(s) are bullish while DBVT’s TA Score has 4 bullish TA indicator(s).

  • CRDF’s TA Score: 5 bullish, 5 bearish.
  • DBVT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CRDF and DBVT are a good buy in the short-term.

Price Growth

CRDF (@Biotechnology) experienced а -7.81% price change this week, while DBVT (@Biotechnology) price change was -3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

CRDF is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CRDF
Daily Signal:
Gain/Loss:
DBVT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTHR571.3829.49
+5.44%
United Therapeutics Corp
DKL54.471.26
+2.37%
Delek Logistics Partners LP
PKE29.720.03
+0.10%
Park Aerospace Corp
OPHC8.69-0.03
-0.34%
OptimumBank Holdings Inc
NWTG1.06-0.05
-4.50%
Newton Golf Company Inc

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with CLDX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-2.48%
CLDX - CRDF
33%
Loosely correlated
-0.71%
AXON - CRDF
33%
Poorly correlated
-0.07%
DBVT - CRDF
32%
Poorly correlated
-4.68%
SNTI - CRDF
32%
Poorly correlated
+3.91%
AMLX - CRDF
31%
Poorly correlated
-3.51%
More

DBVT and

Correlation & Price change

A.I.dvisor tells us that DBVT and CGEN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBVT and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
-4.68%
CGEN - DBVT
33%
Poorly correlated
-1.68%
GPCR - DBVT
32%
Poorly correlated
-7.32%
CRDF - DBVT
32%
Poorly correlated
-2.48%
KYMR - DBVT
32%
Poorly correlated
-1.49%
RXRX - DBVT
31%
Poorly correlated
-1.45%
More